| scholarly article | Q13442814 |
| P2093 | author name string | D Robert Siemens | |
| Harriet Feilotter | |||
| Jaime Snowdon | |||
| Jason Izard | |||
| Sandy Boag | |||
| P2860 | cites work | An extensive class of small RNAs in Caenorhabditis elegans | Q27860626 |
| An abundant class of tiny RNAs with probable regulatory roles in Caenorhabditis elegans | Q27860895 | ||
| Identification of novel genes coding for small expressed RNAs | Q27860917 | ||
| MicroRNAs: genomics, biogenesis, mechanism, and function | Q27861070 | ||
| The 21-nucleotide let-7 RNA regulates developmental timing in Caenorhabditis elegans | Q27861103 | ||
| Embryonic stem cell-specific MicroRNAs | Q28201906 | ||
| Micro-RNA profiling in kidney and bladder cancers | Q28247306 | ||
| MiRNA expression in urothelial carcinomas: important roles of miR-10a, miR-222, miR-125b, miR-7 and miR-452 for tumor stage and metastasis, and frequent homozygous losses of miR-31 | Q28305980 | ||
| Cancer statistics, 2000. | Q33895772 | ||
| Urine based markers of urological malignancy | Q34140108 | ||
| Current bladder tumor tests: does their projected utility fulfill clinical necessity? | Q34189379 | ||
| Stem cells: from epigenetics to microRNAs | Q34417208 | ||
| Non-invasive diagnostic tests for bladder cancer: a review of the literature | Q34458320 | ||
| A robust methodology to study urine microRNA as tumor marker: microRNA-126 and microRNA-182 are related to urinary bladder cancer | Q34976475 | ||
| Clinical evaluation of a multi-target fluorescent in situ hybridization assay for detection of bladder cancer | Q34978029 | ||
| MicroRNA: a new player in stem cells | Q36515065 | ||
| MicroRNAs and their regulatory roles in animals and plants | Q36649761 | ||
| Rapid detection of bladder cancer: a comparative study of point of care tests | Q38555170 | ||
| A microRNA expression ratio defining the invasive phenotype in bladder tumors | Q39938718 | ||
| Review of chromosome studies in urological tumors. II. Cytogenetics and molecular genetics of bladder cancer. | Q40620941 | ||
| Toward the validation of aneusomy detection by fluorescence in situ hybridization in bladder cancer: comparative analysis with cytology, cytogenetics, and clinical features predicts recurrence and defines clinical testing limitations | Q43784757 | ||
| Stem cell division is regulated by the microRNA pathway | Q47070620 | ||
| MicroRNA-143 as a tumor suppressor for bladder cancer. | Q53723022 | ||
| Cytology, flow cytometry, image analysis, and interphase cytogenetics by fluorescence in situ hybridization in the diagnosis of transitional cell carcinoma in bladder washes: a comparative study | Q70935362 | ||
| Urinary nuclear matrix protein as a marker for transitional cell carcinoma of the urinary tract | Q71536578 | ||
| Results of a Multicenter Trial using the BTA Test to Monitor for and Diagnose Recurrent Bladder Cancer | Q71871633 | ||
| Chromosomal imbalances in noninvasive papillary bladder neoplasms (pTa) | Q73010317 | ||
| Performance characteristics of a new monoclonal antibody test for bladder cancer: ImmunoCyt trade mark | Q73365891 | ||
| Improved detection of recurrent bladder cancer using the Bard BTA stat Test | Q73707842 | ||
| Bladder wash cytology, quantitative cytology, and the qualitative BTA test in patients with superficial bladder cancer | Q74147851 | ||
| Can urine bound diagnostic tests replace cystoscopy in the management of bladder cancer? | Q74581865 | ||
| P433 | issue | 1-2 | |
| P921 | main subject | microRNA | Q310899 |
| biomarker | Q864574 | ||
| P304 | page(s) | 28-32 | |
| P577 | publication date | 2012-05-15 | |
| P1433 | published in | Canadian Urological Association journal | Q26842808 |
| P1476 | title | A pilot study of urinary microRNA as a biomarker for urothelial cancer | |
| P478 | volume | 7 |
| Q88857323 | A Carbon Nanotube Reporter of miRNA Hybridization Events In Vivo |
| Q88765264 | A method for extracting and characterizing RNA from urine: For downstream PCR and RNAseq analysis |
| Q26744152 | Aberrantly expressed microRNAs in the context of bladder tumorigenesis |
| Q50069968 | Analysis of miR-96 and miR-133a Expression in Gastrointestinal Neuroendocrine Neoplasms |
| Q36770389 | Bladder cancer detection and monitoring: assessment of urine- and blood-based marker tests |
| Q40612694 | Bladder cancer: Validating what we've got. |
| Q41093549 | Cell-free microRNA expression signatures in urine serve as novel noninvasive biomarkers for diagnosis and recurrence prediction of bladder cancer |
| Q33889872 | Cell-free urinary microRNA-99a and microRNA-125b are diagnostic markers for the non-invasive screening of bladder cancer |
| Q54420629 | Characterization and deep sequencing analysis of exosomal and non-exosomal miRNA in human urine. |
| Q26786185 | Diagnostic Value of MicroRNAs for Urologic Cancers: A Systematic Review and Meta-Analysis |
| Q38369215 | Diagnostic significance of microRNAs as novel biomarkers for bladder cancer: a meta-analysis of ten articles |
| Q35858355 | Diagnostic value of urinary microRNAs as non-invasive biomarkers for bladder cancer: a meta-analysis |
| Q33689126 | Dysregulation of miRNAs in bladder cancer: altered expression with aberrant biogenesis procedure |
| Q45941410 | Expression of CHD1L in bladder cancer and its influence on prognosis and survival. |
| Q33739794 | Expression of urinary miRNAs targeting NLRs inflammasomes in bladder cancer |
| Q26742027 | Extracellular MicroRNA in liquid biopsy: applicability in cancer diagnosis and prevention |
| Q40611991 | Letter: Micro-RNA-125b and its use as a biomarker of systemic malignancies besides urothelial cancers |
| Q38188561 | MULTIPLEX URINARY TESTS FOR BLADDER CANCER DIAGNOSIS. |
| Q38748901 | MiR-126 regulates proliferation and invasion in the bladder cancer BLS cell line by targeting the PIK3R2-mediated PI3K/Akt signaling pathway. |
| Q52603493 | MiRNA extraction from cell-free biofluid using protein corona formed around carboxyl magnetic nanoparticles. |
| Q47683816 | MicroRNA-126 deficiency enhanced the activation and function of CD4+ T cells by elevating IRS-1 pathway. |
| Q33762123 | MicroRNAs in biofluids are novel tools for bladder cancer screening |
| Q38520403 | Molecular markers in bladder cancer: Novel research frontiers |
| Q60910180 | New Insights in Bladder Cancer Diagnosis: Urinary miRNAs and Proteins |
| Q38216129 | Nucleic acid-based biomarkers in body fluids of patients with urologic malignancies. |
| Q50182618 | Quantification of MicroRNAs in Urine-Derived Specimens |
| Q35034340 | Regulation of cancer metastasis by cell-free miRNAs |
| Q52620429 | Serum microRNAs as predictors of risk for non-muscle invasive bladder cancer. |
| Q26825022 | The circulating transcriptome as a source of non-invasive cancer biomarkers: concepts and controversies of non-coding and coding RNA in body fluids |
| Q64104764 | The potential role of miR-126, miR-21 and miR-10b as prognostic biomarkers in renal cell carcinoma |
| Q38800426 | The translational potential of microRNAs as biofluid markers of urological tumours. |
| Q92022312 | Urinary expression of let-7c cluster as non-invasive tool to assess the risk of disease progression in patients with high grade non-muscle invasive bladder Cancer: a pilot study |
| Q90431409 | Urine miRNA as a potential biomarker for bladder cancer detection - a meta-analysis |
| Q35966060 | Urine microRNAs as biomarkers for bladder cancer: a diagnostic meta-analysis |
| Q38137530 | Urine microRNAs as potential noninvasive biomarkers in urologic cancers. |
| Q38967481 | Urothelial Bladder Cancer Urinary Biomarkers |
| Q38239829 | miRNA panels as biomarkers for bladder cancer. |
| Q26797259 | microRNA: Diagnostic Perspective |
Search more.